Sonnet BioTherapeutics Holdings, Inc.
SONN
$1.33
$0.053.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.03% | 10.75% | -1,059.39% | 131.27% | 68.22% |
| Total Depreciation and Amortization | 2.78% | 2.86% | 2.44% | 2.50% | 2.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.87% | -86.04% | 616.23% | -2.58% | 24.00% |
| Change in Net Operating Assets | 226.13% | -602.27% | -106.34% | 113.84% | -110.67% |
| Cash from Operations | 8.20% | -3.28% | -524.10% | 123.41% | 32.19% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 5,270.18% | -98.54% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 58.24% | -35.17% | -950.00% | -- | -- |
| Cash from Financing | 3,347.68% | -108.24% | 6,850.73% | -98.93% | 21,788.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 238.39% | -1,368.26% | -130.32% | 2.37% | 115.74% |